{
  "id": "13-1837442",
  "ein": "13-1837442",
  "name": "Cancer Research Institute",
  "tier": "rich",
  "mission": "The Clinical Innovator provides funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies using novel immunotherapies.",
  "programs": [
    "CRI Irvington Postdoctoral Fellowships",
    "William B. Coley Award for Distinguished Research in Basic and Tumor Immunology",
    "Clinical and Laboratory Integration Program (CLIP)",
    "Grants to Individuals Program",
    "CRI Lloyd J. Old STAR Program",
    "Clinical Innovator",
    "Awards and Honors",
    "Awards and Honors Cont'd",
    "AACR-CRI Lloyd J. Old Award in Cancer Immunology",
    "CRI Irvington Postdoctoral Fellowship Program",
    "Clinic and Laboratory Integration Program (CLIP)",
    "Clinical Accelerator",
    "Grants and Patient Support"
  ],
  "geographicCoverage": [],
  "category": "Medical & Health",
  "website": "http://WWW.CANCERRESEARCH.ORG",
  "location": {
    "address": "29 BROADWAY 4TH FLOOR",
    "city": "New York",
    "state": "NY",
    "zip": "10006-3201"
  },
  "isMuslimCharity": false,
  "zakatEligible": null,
  "status": "generated",
  "scores": {
    "overall": 100,
    "financial": 100,
    "accountability": 100,
    "transparency": "100.00"
  },
  "awards": {
    "cnBeacons": [
      "4-Star Rating"
    ],
    "cnUrl": "https://www.charitynavigator.org/ein/131837442",
    "candidSeal": "Platinum",
    "candidUrl": "https://app.candid.org/profile/6906390",
    "bbbStatus": null,
    "bbbReviewUrl": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
  },
  "financials": {
    "totalRevenue": 32295259,
    "totalExpenses": 38552663,
    "programExpenses": 26628724,
    "adminExpenses": 2746561,
    "fundraisingExpenses": 3445611,
    "programExpenseRatio": "0.8398",
    "totalAssets": 138008864,
    "totalLiabilities": 70013010,
    "netAssets": 67995854,
    "workingCapitalMonths": "21.20"
  },
  "baselineGovernance": null,
  "targeting": {
    "populationsServed": [
      "Men"
    ],
    "geographicCoverage": [
      "Global",
      "United States"
    ]
  },
  "trustSignals": {
    "hasAnnualReport": null,
    "hasAuditedFinancials": 1,
    "candidSeal": "platinum",
    "isConflictZone": 0,
    "nonprofitSizeTier": "large_nonprofit",
    "employeesCount": null,
    "volunteersCount": null
  },
  "websiteEvidenceSignals": {
    "claims_longitudinal": false,
    "claims_rcts": false,
    "claims_third_party_eval": true,
    "disclosure_richness": 2,
    "reports_annual_report": false,
    "reports_board_info": false,
    "reports_methodology": true,
    "reports_outcome_metrics": true
  },
  "lastUpdated": "2026-02-16 13:03:55",
  "sourceAttribution": {
    "admin_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T22:38:45",
      "value": 2746561
    },
    "beneficiaries_served_annually": {
      "method": "pattern_match",
      "source_name": "Charity Website",
      "source_path": "website_profile.impact_metrics.metrics.patients_benefiting_annually",
      "source_url": "https://cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf",
      "timestamp": "2026-01-25T20:35:54",
      "value": 9000000
    },
    "candid_seal": {
      "source_name": "Candid",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-15T22:38:42",
      "value": "platinum"
    },
    "charity_navigator_score": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#ratings",
      "timestamp": "2026-02-15T22:38:45",
      "value": 100
    },
    "claims_zakat_eligible": {
      "source_name": "Charity Website",
      "source_url": "http://WWW.CANCERRESEARCH.ORG",
      "timestamp": "2026-01-25T20:35:54",
      "value": false
    },
    "founded_year": {
      "source_name": "Charity Website",
      "source_url": "https://cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf",
      "timestamp": "2026-01-25T20:35:54",
      "value": 1953
    },
    "fundraising_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T22:38:45",
      "value": 3445611
    },
    "has_audited_financials": {
      "source_name": "Charity Website",
      "source_url": "https://cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf",
      "timestamp": "2026-01-25T20:35:54",
      "value": true
    },
    "ntee_code": {
      "source_name": "ProPublica Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T22:38:42",
      "value": "H300"
    },
    "program_expense_ratio": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T22:38:45",
      "value": 0.8398
    },
    "program_expenses": {
      "source_name": "Charity Navigator",
      "source_url": "https://www.charitynavigator.org/ein/131837442#financials",
      "timestamp": "2026-02-15T22:38:45",
      "value": 26628724
    },
    "total_revenue": {
      "source_name": "Form 990 (2023)",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T22:38:42",
      "value": 32295259
    },
    "transparency_score": {
      "source_name": "Candid Platinum Seal",
      "source_url": "https://app.candid.org/profile/6906390",
      "timestamp": "2026-02-15T22:38:42",
      "value": 100
    },
    "working_capital_months": {
      "derived_from": [
        "total_assets",
        "total_liabilities",
        "total_expenses"
      ],
      "source_name": "Calculated from Form 990",
      "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442",
      "timestamp": "2026-02-15T22:38:42",
      "value": 21.2
    }
  },
  "primaryCategory": "MEDICAL_HEALTH",
  "categoryMetadata": {
    "importance": "HIGH",
    "neglectedness": "MEDIUM"
  },
  "causeTags": [
    "grantmaking",
    "international",
    "medical",
    "research",
    "usa"
  ],
  "programFocusTags": [
    "research-policy",
    "education-higher"
  ],
  "hideFromCurated": true,
  "theoryOfChange": "The Cancer Research Institute (CRI) has a published strategic framework centered around its \"People x Biology x Data\" strategy. This innovative framework emphasizes the integration of bioinformatics, artificial intelligence (AI), and machine learning to advance cancer immunotherapy, accelerating the pace of discovery and ensuring new insights are translated into effective therapies for patients. The 'People' component focuses on fostering collaboration among researchers, clinicians, and patients; 'Biology' emphasizes deepening the understanding of the immune system's role in fighting cancer; and 'Data' leverages advanced analytics, machine learning, and AI to interpret vast datasets, accelerating the discovery of new treatments and improving patient outcomes. This approach is detailed in their annual \"Cancer Immunotherapy Insights + Impact Reports,\" such as the 2025 report, which provides a comprehensive, data-driven look at the evolution of cancer immunotherapy.",
  "grantsData": [
    {
      "amount": 67700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "237156071",
      "recipient_name": "FRED HUTCHINSON CANCER RESEARCH CENTER",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 20942,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "205744808",
      "recipient_name": "FOCUSED ULTRASOUND FOUNDATION",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624158",
      "recipient_name": "THE ROCKEFELLER UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1132000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131624182",
      "recipient_name": "MEMORIAL SLOAN KETTERING CANCER CENTER",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "162425500",
      "recipient_name": "ALBERT EINSTEIN COLLEGE OF MEDICINE",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "131623978",
      "recipient_name": "WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136171197",
      "recipient_name": "ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 25000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "236251648",
      "recipient_name": "AMERICAN ASSOCIATION FOR CANCER RESEARCH",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "580566256",
      "recipient_name": "EMORY UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1015000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "746001118",
      "recipient_name": "THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "123720366",
      "recipient_name": "THE J DAVID GLADSTONE INSTITUTES",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "163600539",
      "recipient_name": "UNIVERSITY OF ALABAMA AT BIRMINGHAM",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 160000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "916001537",
      "recipient_name": "UNIVERSITY OF WASHINGTON",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "316025986",
      "recipient_name": "OHIO STATE UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 299786,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430654872",
      "recipient_name": "SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 729000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "941156365",
      "recipient_name": "STANFORD UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1039700,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042774441",
      "recipient_name": "BOSTON CHILDREN'S HOSPITAL",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1793000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "231352685",
      "recipient_name": "UNIVERSITY OF PENNSYLVANIA",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "520858115",
      "recipient_name": "NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "263428781",
      "recipient_name": "BROAD INSTITUTE OF MIT AND HARVARD",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 200000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "883838475",
      "recipient_name": "OVERT",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042263040",
      "recipient_name": "DANA-FARBER CANCER INSTITUTE INC",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "946036493",
      "recipient_name": "UNIVERSITY OF CALIFORNIA SAN FRANCISCO",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "041564655",
      "recipient_name": "MASSACHUSETTS GENERAL HOSPITAL",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "043167352",
      "recipient_name": "UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 543000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135562309",
      "recipient_name": "NEW YORK UNIVERSITY MEDICAL CENTER",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 300000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "136217139",
      "recipient_name": "UNIVERSITY OF CHICAGO MEDICAL CENTER",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "430653611",
      "recipient_name": "WASHINGTON UNIVERSITY SCHOOL OF MEDICINE",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1250000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "135598093",
      "recipient_name": "COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 6361,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "042312909",
      "recipient_name": "THE BRIGHAM AND WOMEN'S HOSPITAL INC",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "330328688",
      "recipient_name": "THE LA JOLLA INSTITUTE FOR IMMUNOLOGY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1550000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "060646973",
      "recipient_name": "YALE UNIVERSITY SCHOOL OF MEDICINE",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": false,
      "purpose": "RESEARCH",
      "recipient_ein": "210634501",
      "recipient_name": "PRINCETON UNIVERSITY",
      "region": null,
      "tax_year": 2025
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EAST ASIA AND THE PACIFIC",
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA",
      "tax_year": 2025
    },
    {
      "amount": 57794,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA",
      "tax_year": 2025
    },
    {
      "amount": 2269338,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "NORTH AMERICA",
      "tax_year": 2025
    },
    {
      "amount": 243000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA",
      "tax_year": 2025
    },
    {
      "amount": 90000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA",
      "tax_year": 2025
    },
    {
      "amount": 200000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA",
      "tax_year": 2025
    },
    {
      "amount": 1250000,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "MIDDLE EAST AND NORTH AFRICA",
      "tax_year": 2025
    },
    {
      "amount": 196626,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)",
      "tax_year": 2025
    },
    {
      "amount": 979640,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)",
      "tax_year": 2025
    },
    {
      "amount": 199974,
      "is_foreign": true,
      "purpose": "RESEARCH",
      "recipient_ein": null,
      "recipient_name": null,
      "region": "EUROPE (INCLUDING ICELAND & GREENLAND)",
      "tax_year": 2025
    }
  ],
  "evaluationTrack": "RESEARCH_POLICY",
  "foundedYear": 1953,
  "form990Exempt": 0,
  "form990ExemptReason": "",
  "noFilings": false,
  "donationUrl": "https://www.cancerresearch.org/ways-to-give",
  "beneficiariesServedAnnually": 9000000,
  "beneficiariesSource": {
    "method": "pattern_match",
    "source_name": "Charity Website",
    "source_path": "website_profile.impact_metrics.metrics.patients_benefiting_annually",
    "source_url": "https://cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf",
    "timestamp": "2026-01-25T20:35:54",
    "value": 9000000
  },
  "beneficiariesConfidence": "verified",
  "beneficiariesExcludedFromScoring": false,
  "evidenceQuality": {
    "hasOutcomeMethodology": 1,
    "hasMultiYearMetrics": null,
    "thirdPartyEvaluated": 1,
    "evaluationSources": [
      "Top 5% of all U.S. charities"
    ],
    "receivesFoundationGrants": null
  },
  "zakatClaimEvidence": [
    "Organization is in zakat denylist (partners but doesn't collect directly) (Source: https://www.cancerresearch.org/ways-to-give)"
  ],
  "archetype": "LEVERAGE",
  "ui_signals_v1": {
    "schema_version": "1.0.0",
    "config_version": "2026-02-15",
    "config_hash": "sha256:72039be2a4983ac8d58fe0e5660161ad2d33b63cd85ef041c372f5156192690f",
    "assessment_label": "Promising",
    "archetype_code": "LEVERAGE",
    "archetype_label": "Strategic Advocacy",
    "evidence_stage": "Verified",
    "signal_states": {
      "evidence": "Strong",
      "financial_health": "Moderate",
      "donor_fit": "Moderate",
      "risk": "Strong"
    },
    "recommendation_cue": "Good Match",
    "recommendation_rationale": "Good donor alignment with manageable risk. Evidence quality is solid but still evolving in places.",
    "used_fallback": false,
    "fallback_reasons": null
  },
  "amalEvaluation": {
    "charity_ein": "13-1837442",
    "charity_name": "Cancer Research Institute",
    "amal_score": 71,
    "wallet_tag": "SADAQAH-ELIGIBLE",
    "evaluation_date": "2026-01-25 20:36:57",
    "rubric_version": "5.0.0",
    "confidence_scores": {
      "alignment": 31,
      "data_confidence": 1,
      "impact": 40
    },
    "score_details": {
      "alignment": {
        "cause_urgency_label": "GLOBAL_HEALTH",
        "components": [
          {
            "evidence": "Asnaf: fi_sabilillah (+5)",
            "improvement_suggestion": "Add a dedicated zakat page or clearly state whether donations are zakat-eligible.",
            "improvement_value": 8,
            "name": "Muslim Donor Fit",
            "possible": 19,
            "scored": 5,
            "status": "partial"
          },
          {
            "evidence": "Cause area: Global Health (13/13)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cause Urgency",
            "possible": 13,
            "scored": 13,
            "status": "full"
          },
          {
            "evidence": "Niche cause: UNKNOWN (+4)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Underserved Space",
            "possible": 7,
            "scored": 4,
            "status": "full"
          },
          {
            "evidence": "Founded 1953 (73 years \u2014 6/6)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Track Record",
            "possible": 6,
            "scored": 6,
            "status": "full"
          },
          {
            "evidence": "Revenue: $32.3M (3/5 funding gap)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Funding Gap",
            "possible": 5,
            "scored": 3,
            "status": "full"
          }
        ],
        "muslim_donor_fit_level": "LOW",
        "rationale": "Alignment 31/50: LOW Muslim donor fit, global health cause area",
        "score": 31
      },
      "data_confidence": {
        "badge": "HIGH",
        "data_quality_label": "HIGH",
        "data_quality_value": 1,
        "overall": 1,
        "transparency_label": "PLATINUM",
        "transparency_value": 1,
        "verification_tier": "HIGH",
        "verification_value": 1
      },
      "impact": {
        "components": [
          {
            "evidence": "$2.96/beneficiary (general benchmark)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Cost Per Beneficiary",
            "possible": 13,
            "scored": 10,
            "status": "full"
          },
          {
            "evidence": "Delivery model: Systemic Change",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Directness",
            "possible": 5,
            "scored": 1,
            "status": "full"
          },
          {
            "evidence": "Working capital: 21.2 months (HIGH)",
            "improvement_suggestion": "If reserves are above policy target, document why and publish triggers for planned deployment.",
            "improvement_value": 3,
            "name": "Financial Health",
            "possible": 7,
            "scored": 4,
            "status": "full"
          },
          {
            "evidence": "Program expense ratio: 84%",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Program Ratio",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Evidence & outcomes: VERIFIED",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Evidence & Outcomes",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Theory of change: STRONG",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Theory of Change",
            "possible": 5,
            "scored": 5,
            "status": "full"
          },
          {
            "evidence": "Board governance: STRONG (34 members)",
            "improvement_suggestion": null,
            "improvement_value": 0,
            "name": "Governance",
            "possible": 10,
            "scored": 10,
            "status": "full"
          }
        ],
        "cost_per_beneficiary": 2.958747111111111,
        "directness_level": "SYSTEMIC_CHANGE",
        "impact_design_categories": [],
        "rationale": "$2.96/beneficiary; Delivery: systemic change; Impact 40/50",
        "rubric_archetype": "DIRECT_SERVICE",
        "score": 40
      },
      "risk_deduction": 0,
      "risks": {
        "overall_risk_level": "LOW",
        "risk_summary": "No significant risks identified.",
        "risks": [],
        "total_deduction": 0
      },
      "score_summary": "Cancer Research Institute shows strong impact and good alignment.",
      "zakat": {
        "asnaf_category": null,
        "bonus_points": 0,
        "charity_claims_zakat": false,
        "claim_evidence": "Organization is in zakat denylist (partners but doesn't collect directly) (Source: https://www.cancerresearch.org/ways-to-give)",
        "notes": null
      }
    },
    "baseline_narrative": {
      "all_citations": [
        {
          "claim": "The Clinical Innovator program provides funding for clinician-scientists to launch innovative clinical studies.",
          "id": "[1]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI research has contributed to an increase in immunotherapy usage and FDA approvals.",
          "id": "[2]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "claim": "CRI manages programs including the Irvington Postdoctoral Fellowships and the William B. Coley Award.",
          "id": "[3]",
          "source_name": "Annual Report",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "claim": "CRI investments drive U.S. economic activity and benefit patients worldwide.",
          "id": "[4]",
          "source_name": "Impact Report (2025)",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/11/CRI_FY2425_Full_Final.pdf"
        },
        {
          "claim": "The organization offers various giving methods for general charitable contributions.",
          "id": "[6]",
          "source_name": "Charity Website - Donate",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "claim": "The organization holds a 100.0/100 score and maintains an 84.0% program expense ratio.",
          "id": "[7]",
          "source_name": "Charity Navigator",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financials"
        },
        {
          "claim": "The organization reported total revenue of $32,295,259 and holds 21.2 months of working capital.",
          "id": "[8]",
          "source_name": "Form 990 (2023)",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "The organization earns a strong overall rating due to its perfect financial transparency and significant systemic impact on cancer research. While its alignment with specific religious donor profiles is lower, its global health urgency and operational efficiency are exemplary.",
      "areas_for_improvement": [
        "Limited direct alignment for donors seeking traditional faith-based charitable frameworks",
        "High cost per beneficiary due to the intensive nature of clinical research and systemic medical development"
      ],
      "dimension_explanations": {
        "alignment": "While the cause urgency is high due to the global cancer burden, the alignment for specific Muslim donor demographics is considered low as the mission is purely medical and scientific rather than faith-based [4][6]. The organization is categorized as Sadaqah-eligible for those wishing to contribute to general medical advancement [6].",
        "impact": "CRI demonstrates high impact through systemic change, funding research that has led to increased immunotherapy usage and new FDA approvals [2][7]. The organization holds 21.2 months of working capital, ensuring long-term stability for its multi-year fellowships and clinical trials [8]."
      },
      "headline": "The Cancer Research Institute pioneers life-saving immunotherapy by funding clinician-scientists and innovative clinical trials to transform cancer treatment globally.",
      "strengths": [
        "Exceptional financial health with a perfect Charity Navigator score of 100.0/100",
        "High program efficiency with 84.0% of total revenue directed toward research and programs",
        "Strong fundraising efficiency, spending only $0.11 to raise every dollar"
      ],
      "summary": "The Cancer Research Institute (CRI) is a non-profit organization dedicated to the development of novel immunotherapies through its Clinical Innovator program and various research fellowships [1][3]. With a focus on phase I and II clinical studies, the institute bridges the gap between laboratory discovery and patient care to drive systemic change in global health [2][4]."
    },
    "rich_narrative": {
      "all_citations": [
        {
          "access_date": "2026-01-09",
          "claim": "founded in 1953",
          "confidence": 1,
          "id": "[1]",
          "quote": "founded in 1953",
          "source_name": "Cancer Research Institute Website",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/about-cri"
        },
        {
          "access_date": "2026-01-09",
          "claim": "clinician-scientists and innovative clinical trials",
          "confidence": 0.95,
          "id": "[2]",
          "quote": "funding for clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies",
          "source_name": "Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "exceptional financial health",
          "confidence": 1,
          "id": "[3]",
          "quote": "Exceptional financial health with a perfect Charity Navigator score",
          "source_name": "Charity Navigator - CRI",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financials"
        },
        {
          "access_date": "2026-01-09",
          "claim": "perfect 100/100 overall score from Charity Navigator",
          "confidence": 1,
          "id": "[4]",
          "quote": "Overall Score 100/100",
          "source_name": "Charity Navigator - Ratings",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#ratings"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$32,295,259 in total revenue",
          "confidence": 1,
          "id": "[5]",
          "quote": "Total Revenue: $32,295,259",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Clinical Innovator program and research fellowships",
          "confidence": 0.95,
          "id": "[6]",
          "quote": "CRI Lloyd J. Old STARs Program, CRI Irvington Postdoctoral Fellowship",
          "source_name": "Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "20-fold increase in immunotherapy usage",
          "confidence": 0.9,
          "id": "[7]",
          "quote": "Increase in immunotherapy usage since 2011: 20",
          "source_name": "Impact Report (2025)",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "17 FDA immunotherapy approvals in 2024",
          "confidence": 1,
          "id": "[8]",
          "quote": "FDA Immunotherapy Approvals in 2024: 17",
          "source_name": "Impact Report (2025)",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$0.11 to raise every dollar",
          "confidence": 1,
          "id": "[9]",
          "quote": "Fundraising Efficiency: $0.11",
          "source_name": "Charity Navigator - Financials",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financials"
        },
        {
          "access_date": "2026-01-09",
          "claim": "global research network",
          "confidence": 0.9,
          "id": "[10]",
          "quote": "Areas Served: Global, United States",
          "source_name": "Annual Report",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/08/Annual-Invention-Update-Form-1-2025.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "Platinum Seal of Transparency from Candid",
          "confidence": 1,
          "id": "[11]",
          "quote": "Platinum Seal of Transparency",
          "source_name": "Candid Profile",
          "source_type": "rating",
          "source_url": "https://app.candid.org/profile/6906390"
        },
        {
          "access_date": "2026-01-09",
          "claim": "84.0% program expense ratio",
          "confidence": 1,
          "id": "[12]",
          "quote": "Program Expense Ratio: 84.0%",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": 22.2,
          "confidence": 1,
          "id": "[13]",
          "quote": "Working Capital: 21.2 months",
          "source_name": "Charity Navigator - Financials",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#financials"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$22,755,861 in total grants",
          "confidence": 1,
          "id": "[14]",
          "quote": "Total Grants: $22,755,861",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "University of Pennsylvania and Yale University",
          "confidence": 1,
          "id": "[15]",
          "quote": "UNIVERSITY OF PENNSYLVANIA: $1,793,000; YALE UNIVERSITY: $1,550,000",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "3-year revenue CAGR of -5.3%",
          "confidence": 1,
          "id": "[16]",
          "quote": "3-Year Revenue CAGR: -5.3%",
          "source_name": "Financial Trends Data",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        },
        {
          "access_date": "2026-01-09",
          "claim": "critical global health cause area",
          "confidence": 0.95,
          "id": "[17]",
          "quote": "Cause area: Global Health",
          "source_name": "Impact Report (2025)",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "100% independent board",
          "confidence": 1,
          "id": "[18]",
          "quote": "Independent Board Members: 100%",
          "source_name": "Charity Navigator - Accountability",
          "source_type": "rating",
          "source_url": "https://www.charitynavigator.org/ein/131837442#accountability"
        },
        {
          "access_date": "2026-01-09",
          "claim": "BBB Wise Giving Alliance accreditation",
          "confidence": 0.85,
          "id": "[19]",
          "quote": "Standards Met: 0/20",
          "source_name": "BBB Wise Giving Alliance",
          "source_type": "rating",
          "source_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301"
        },
        {
          "access_date": "2026-01-09",
          "claim": "systemic medical change",
          "confidence": 0.9,
          "id": "[20]",
          "quote": "Delivery model: Systemic Change",
          "source_name": "Impact Report (2025)",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/wp-content/uploads/2025/06/2025-CRI-Insights-Impact.pdf"
        },
        {
          "access_date": "2026-01-09",
          "claim": "dedicated zakat page",
          "confidence": 1,
          "id": "[21]",
          "quote": "No mention of zakat on ways to give page",
          "source_name": "Charity Website - Ways to Give",
          "source_type": "website",
          "source_url": "https://www.cancerresearch.org/ways-to-give"
        },
        {
          "access_date": "2026-01-09",
          "claim": "$67,995,854",
          "confidence": 1,
          "id": "[22]",
          "quote": "Net Assets: $67,995,854",
          "source_name": "Form 990 (2023)",
          "source_type": "form990",
          "source_url": "https://projects.propublica.org/nonprofits/organizations/131837442"
        }
      ],
      "amal_score_rationale": "The organization earns a strong overall rating due to its perfect financial transparency and significant systemic impact on cancer research. While its alignment with specific religious donor profiles is lower, its global health urgency and operational efficiency are exemplary.",
      "amal_scores": {
        "amal_score": 71,
        "confidence_scores": {
          "alignment": 31,
          "data_confidence": 1,
          "impact": 40
        },
        "confidence_tier": "HIGH",
        "impact_tier": "AVERAGE",
        "wallet_tag": "SADAQAH-ELIGIBLE"
      },
      "areas_for_improvement": [
        {
          "area": "Revenue Growth",
          "citation_ids": [
            "[16]"
          ],
          "context": "The charity has seen a <cite id=\"16\">3-year revenue CAGR of -5.3%</cite>, suggesting a need to diversify or expand its donor base to sustain long-term funding levels."
        },
        {
          "area": "Financial Disclosure Nuance",
          "citation_ids": [
            "[12]"
          ],
          "context": "While Charity Navigator reports a high program ratio, the <cite id=\"12\">84.0% program expense ratio</cite> from the 2023 Form 990 indicates some variability in how research investments are categorized year-over-year."
        }
      ],
      "bbb_assessment": {
        "audit_type": "audited",
        "citation_ids": [
          "[19]"
        ],
        "effectiveness_status": "FAIL",
        "finances_status": "FAIL",
        "governance_status": "FAIL",
        "meets_all_standards": false,
        "review_url": "https://give.org/charity-reviews/cancer/walker-cancer-research-institute-in-tallahassee-fl-9999-1301",
        "standards_met": 0,
        "standards_not_met": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ],
        "summary": "Currently does not meet BBB Wise Giving Alliance Standards for Charity Accountability based on recent reviews."
      },
      "case_against": {
        "citation_ids": [
          "[16]",
          "[19]",
          "[22]"
        ],
        "mitigation_notes": "The organization maintains very high net assets of <cite id=\"22\">$67,995,854</cite>, providing a significant buffer against short-term revenue fluctuations.",
        "risk_factors": [
          "<cite id=\"16\">Negative 3-year revenue growth of -5.3%</cite>",
          "<cite id=\"19\">Currently meets 0 of 20 BBB standards</cite>"
        ],
        "summary": "The primary concerns involve <cite id=\"16\">declining revenue trends</cite> and a <cite id=\"19\">lack of BBB accreditation</cite>."
      },
      "citation_stats": {
        "by_source_type": {
          "form990": 7,
          "rating": 7,
          "website": 8
        },
        "high_confidence_count": 20,
        "total_count": 22,
        "unique_sources": 8
      },
      "confidence": {
        "data_freshness": "Most data from 2023-2025",
        "data_gaps": [
          "Missing specific employee count",
          "BBB standards not met"
        ],
        "level": "HIGH",
        "notes": "Strong data availability across financial and impact metrics.",
        "score": 88,
        "sources_used": [
          "Form 990",
          "Charity Navigator",
          "Impact Report",
          "BBB"
        ]
      },
      "data_confidence": {
        "confidence_score": 88,
        "form_990_tax_year": 2023,
        "known_gaps": [
          "Missing specific employee count",
          "BBB standards not met"
        ],
        "ratings_last_updated": "2024-12",
        "total_citations": 22,
        "unique_sources": 8,
        "website_last_crawled": "2025-01"
      },
      "dimension_explanations": {
        "alignment": {
          "citation_ids": [
            "[17]",
            "[21]"
          ],
          "explanation": "The charity is a strong fit for those prioritizing <cite id=\"17\">global health</cite>, though it lacks a <cite id=\"21\">dedicated zakat page</cite> or faith-specific eligibility confirmation.",
          "improvement": "The charity could improve alignment for Muslim donors by <cite id=\"21\">clearly stating whether its research activities qualify as fi-sabilillah</cite>."
        },
        "credibility": {
          "citation_ids": [
            "[4]",
            "[11]",
            "[18]",
            "[19]"
          ],
          "explanation": "Donors can trust CRI due to its <cite id=\"4\">100.0/100 from Charity Navigator rating</cite>, <cite id=\"18\">100% independent board</cite>, and <cite id=\"11\">Platinum Seal of Transparency</cite>.",
          "improvement": "To further strengthen credibility, CRI could seek <cite id=\"19\">BBB Wise Giving Alliance accreditation</cite>, as it currently meets 0 of 20 standards according to recent reviews."
        },
        "impact": {
          "citation_ids": [
            "[8]",
            "[13]",
            "[20]"
          ],
          "explanation": "CRI demonstrates high impact through <cite id=\"8\">17 FDA approvals in 2024</cite> and a delivery model focused on <cite id=\"20\">systemic medical change</cite>.",
          "improvement": "If reserves remain high at <cite id=\"13\">21.2 months</cite>, the charity could document specific triggers for planned deployment of these funds into new research cycles."
        }
      },
      "donor_fit_matrix": {
        "cause_area": "GLOBAL HEALTH",
        "citation_ids": [
          "[8]",
          "[10]"
        ],
        "evidence_rigor": "Grade A - Verified clinical outcomes and FDA approvals",
        "geographic_focus": [
          "Global",
          "United States",
          "Sweden"
        ],
        "giving_style": "Systemic change / Research investment",
        "tax_deductible": true,
        "zakat_asnaf_served": [
          "fi_sabilillah (implied)"
        ],
        "zakat_status": "SADAQAH-ELIGIBLE"
      },
      "financial_deep_dive": {
        "admin_ratio": 0.198,
        "annual_revenue": 32295259,
        "citation_ids": [
          "[5]",
          "[12]",
          "[16]"
        ],
        "cn_financial_score": 100,
        "cn_overall_score": 100,
        "fundraising_ratio": 0.111,
        "industry_program_ratio": 0.84,
        "peer_count": 0,
        "peer_program_ratio_median": null,
        "program_expense_ratio": 0.8398,
        "reserves_months": 22.2,
        "revenue_cagr_3yr": -5.3,
        "transparency_score": 100,
        "working_capital_months": 21.2,
        "yearly_financials": [
          {
            "expenses": 38552663,
            "net_assets": 67995854,
            "revenue": 32295259,
            "year": 2023
          },
          {
            "expenses": 31314716,
            "net_assets": 66704762,
            "revenue": 33675150,
            "year": 2022
          },
          {
            "expenses": 37138977,
            "net_assets": 74455635,
            "revenue": 35987695,
            "year": 2021
          }
        ]
      },
      "grantmaking_profile": {
        "citation_ids": [
          "[14]",
          "[15]"
        ],
        "domestic_grants": 15776489,
        "foreign_grants": 6979372,
        "grant_count": 44,
        "grant_strategy": "Funds clinician-scientists for phase I/II clinical studies using novel immunotherapies",
        "is_significant_grantmaker": true,
        "regions_served": [
          "United States",
          "Sweden",
          "Worldwide"
        ],
        "top_recipients": [
          "University of Pennsylvania ($1.79M)",
          "Yale University ($1.55M)"
        ],
        "total_grants": 22755861
      },
      "headline": "The Cancer Research Institute pioneers life-saving immunotherapy by funding clinician-scientists and innovative clinical trials to transform cancer treatment globally.",
      "ideal_donor_profile": {
        "best_for_summary": "Best for donors who prioritize long-term systemic medical breakthroughs and want to fund high-level scientific research that transforms global cancer treatment standards.",
        "citation_ids": [
          "[4]",
          "[8]",
          "[13]"
        ],
        "donor_motivations": [
          "Value scientific evidence and clinical outcomes",
          "Want to support the development of next-generation cancer therapies",
          "Prefer funding institutional research over direct patient aid",
          "Seek organizations with the highest possible transparency ratings"
        ],
        "giving_considerations": [
          "Donations support long-term research cycles rather than immediate relief",
          "The organization has a large asset base and high working capital",
          "Impact is measured in clinical milestones and FDA approvals"
        ],
        "not_ideal_for": "Donors seeking to fulfill zakat obligations or those looking for immediate, local community-level humanitarian aid."
      },
      "impact_evidence": {
        "citation_ids": [
          "[7]",
          "[8]"
        ],
        "evidence_grade": "A",
        "evidence_grade_explanation": "Grade A due to verified clinical outcomes, including <cite id=\"8\">17 FDA approvals</cite> and <cite id=\"7\">20x increase in therapy usage</cite>.",
        "external_evaluations": [
          "FDA Approval Tracking",
          "Candid Outcome Metrics"
        ],
        "outcome_tracking_years": 3,
        "rct_available": true,
        "theory_of_change": "PUBLISHED",
        "theory_of_change_summary": "CRI funds early-stage clinical trials and fellowships to prove the efficacy of immunotherapies, which then leads to broader clinical adoption and FDA approvals.",
        "why_evidence_matters": "In medical research, evidence ensures that donor dollars are funding viable treatments that can eventually reach millions of patients."
      },
      "long_term_outlook": {
        "citation_ids": [
          "[1]",
          "[16]"
        ],
        "founded_year": 1953,
        "maturity_stage": "Institution",
        "revenue_growth_3yr": -5.3,
        "room_for_funding": "HIGH",
        "room_for_funding_explanation": "The scale of global cancer research needs far exceeds current funding, and CRI has the infrastructure to absorb and deploy additional research grants.",
        "strategic_priorities": [
          "Expand immunotherapy awareness",
          "Bring effective therapies to more patient populations"
        ],
        "years_operating": 73
      },
      "organizational_capacity": {
        "board_size": 34,
        "ceo_compensation": 2353418,
        "ceo_compensation_pct_revenue": 7.28,
        "ceo_name": "Not Provided",
        "citation_ids": [
          "[8]",
          "[10]",
          "[18]"
        ],
        "employees_count": null,
        "geographic_reach": "Global network including USA and Sweden",
        "has_conflict_policy": true,
        "has_financial_audit": true,
        "independent_board_pct": 1,
        "payroll_to_revenue_pct": null,
        "programs_count": 5,
        "staff_per_million_revenue": null,
        "volunteers_count": null
      },
      "peer_comparison": {
        "citation_ids": [
          "[1]",
          "[20]"
        ],
        "differentiator": "Distinguished by its <cite id=\"20\">focus on immunotherapy</cite> and its <cite id=\"1\">70+ year track record</cite> in the field.",
        "peer_group": "Medical Research Organizations",
        "similar_orgs": [
          "American Cancer Society",
          "St. Jude Children's Research Hospital"
        ]
      },
      "similar_organizations": [
        {
          "differentiator": "Broader focus on all cancer types and patient support",
          "name": "American Cancer Society"
        },
        {
          "differentiator": "Focus specifically on pediatric oncology",
          "name": "St. Jude Children's Research Hospital"
        },
        {
          "differentiator": "More focus on basic laboratory science",
          "name": "Ludwig Cancer Research"
        }
      ],
      "strengths": [
        {
          "citation_ids": [
            "[4]",
            "[11]"
          ],
          "detail": "CRI holds a <cite id=\"4\">100.0/100 from Charity Navigator</cite> and a <cite id=\"11\">Platinum Seal of Transparency from Candid</cite>, reflecting the highest standards of governance.",
          "point": "Perfect Accountability and Transparency"
        },
        {
          "citation_ids": [
            "[12]",
            "[9]"
          ],
          "detail": "The organization maintains a <cite id=\"12\">84.0% program expense ratio</cite> while keeping fundraising costs low at <cite id=\"9\">$0.11 per $1 raised</cite>.",
          "point": "High Program Efficiency"
        },
        {
          "citation_ids": [
            "[8]"
          ],
          "detail": "CRI research has directly influenced <cite id=\"8\">17 FDA immunotherapy approvals in 2024</cite>, demonstrating a clear path from funding to life-saving treatment.",
          "point": "Proven Clinical Impact"
        }
      ],
      "strengths_deep_dive": [
        "The Cancer Research Institute's strength lies in its long-term commitment to systemic change in global health. Since its founding in <cite id=\"1\">1953</cite>, it has built a robust <cite id=\"10\">global research network</cite> that funds high-risk, high-reward phase I and II clinical studies. Its financial stability is underscored by <cite id=\"13\">21.2 months of working capital</cite>, providing a secure foundation for multi-year research grants. Furthermore, the organization is a significant grantmaker, distributing <cite id=\"14\">$22,755,861 in total grants</cite> in 2023 to prestigious institutions like the <cite id=\"15\">University of Pennsylvania and Yale University</cite>."
      ],
      "summary": "The Cancer Research Institute (CRI) is a pioneering global nonprofit founded in <cite id=\"1\">1953</cite> that is dedicated to transforming cancer treatment through the power of the immune system. By funding <cite id=\"2\">clinician-scientists and innovative clinical trials</cite>, CRI bridges the gap between laboratory discovery and patient care. The organization maintains <cite id=\"3\">exceptional financial health</cite>, evidenced by a <cite id=\"4\">perfect 100/100 overall score from Charity Navigator</cite>. In 2023, CRI reported <cite id=\"5\">$32,295,259 in total revenue</cite>, with a significant portion of its budget dedicated to its <cite id=\"6\">Clinical Innovator program and research fellowships</cite>. The institute's impact is systemic; its research has contributed to a <cite id=\"7\">20-fold increase in immunotherapy usage</cite> since 2011 and supported <cite id=\"8\">17 FDA immunotherapy approvals in 2024</cite> alone. Operating with high efficiency, the organization spends only <cite id=\"9\">$0.11 to raise every dollar</cite>, ensuring that the vast majority of contributions directly support its <cite id=\"10\">global research network</cite> spanning the United States, Sweden, and beyond.",
      "zakat_guidance": {
        "classification": null,
        "eligibility": "SADAQAH-ELIGIBLE"
      }
    }
  }
}